Oxford Biomedica plc (LON:OXB – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 455 ($5.65) and last traded at GBX 444 ($5.51), with a volume of 467163 shares trading hands. The stock had previously closed at GBX 416 ($5.17).
Oxford Biomedica Stock Down 2.4 %
The company has a market capitalization of £435.14 million, a PE ratio of -286.81 and a beta of 1.09. The company has a debt-to-equity ratio of 154.88, a quick ratio of 1.67 and a current ratio of 2.35. The stock’s 50 day moving average is GBX 420.29 and its 200 day moving average is GBX 388.15.
Oxford Biomedica Company Profile
One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Featured Stories
- Five stocks we like better than Oxford Biomedica
- Investing In Automotive Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- There Are Different Types of Stock To Invest In
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
